Sale disclosed
Jamie L. Reynoso
CEO, Medicare Advantage
Class A Common Stock
- Reported value
- $9.29K
- Reported price
- $4.63 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
CLOVER HEALTH INVESTMENTS, CORP. /DE
Last 30 daysNo qualifying insider buying. Sales: $3M by 5 insiders.
Showing the first 6 of 49 trades on this page.
CEO, Medicare Advantage
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
Director
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
VP OF FINANCE AND CONTROLLER
Class A Common Stock
CEO, Counterpart Health
Class A Common Stock
Chief Legal Officer
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
VP OF FINANCE AND CONTROLLER
Class A Common Stock
Interim CFO
Class A Common Stock
Chief Legal Officer
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Interim CFO
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Class A Common Stock
Chief Legal Officer
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
Chief Executive Officer
Class A Common Stock
CEO, Counterpart Health
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
Chief Legal Officer
Class A Common Stock
Interim CFO
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
Chief Executive Officer
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
VP OF FINANCE AND CONTROLLER
Class A Common Stock
Chief Legal Officer
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
CEO, Counterpart Health
Class A Common Stock
Director
Class A Common Stock
Interim CFO
Class A Common Stock
CEO of Clover Care Services
Class A Common Stock
Chief Executive Officer
Class A Common Stock
CEO of Clover Care Services
Class A Common Stock
CEO of Clover Care Services
Class A Common Stock
Chief Legal Officer
Class A Common Stock
Chief Executive Officer
Class A Common Stock
Interim CFO
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
CEO, Counterpart Health
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
CEO of Clover Care Services
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
CEO, Medicare Advantage
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Class A Common Stock
CEO, Counterpart Health
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Legal Officer
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 2,006$4.63 / share | $9.29K | Oct 7Filed Oct 7 · 0d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 8,750$4.42 / share | $38.68K | Oct 5Filed Oct 5 · 0d later | SEC filing |
| Director | Class A Common StockGrant or award | 12,481Award · no purchase price | Non-cash award | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Director | Class A Common StockGrant or award | 12,481Award · no purchase price | Non-cash award | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Chief Executive Officer | Class A Common StockSale10b5-1 | 318,806$4.19 / share | $1.34M | Oct 1Filed Oct 2 · 1d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 1,921$4.56 / share | $8.76K | Sep 17Filed Sep 18 · 1d later | SEC filing |
| VP OF FINANCE AND CONTROLLER | Class A Common StockSale10b5-1 | 3,170$4.64 / share | $14.71K | Sep 16Filed Sep 17 · 1d later | SEC filing |
| CEO, Counterpart Health | Class A Common StockSale10b5-1 | 300,000$4.72 / share | $1.42M | Sep 15Filed Sep 16 · 1d later | SEC filing |
| Chief Legal Officer | Class A Common StockSale10b5-1 | 6,846$4.78 / share | $32.72K | Sep 15Filed Sep 15 · 0d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 9,273$4.78 / share | $44.32K | Sep 15Filed Sep 15 · 0d later | SEC filing |
| VP OF FINANCE AND CONTROLLER | Class A Common StockSale | 20,000$5.16 / share | $103.2K | Sep 14Filed Sep 14 · 0d later | SEC filing |
| Interim CFO | Class A Common StockSale10b5-1 | 17,775$4.39 / share | $78.03K | Aug 17Filed Aug 17 · 0d later | SEC filing |
| Chief Legal Officer | Class A Common StockGrant or award | 108,695Award · no purchase price | Non-cash award | Aug 12Filed Aug 13 · 1d later | SEC filing |
| Interim CFO | Class A Common StockGrant or award | 54,347Award · no purchase price | Non-cash award | Aug 12Filed Aug 13 · 1d later | SEC filing |
| Chief Executive Officer | Class A Common StockSale10b5-1 | 87,798$4.65 / share | $408.26K | Aug 10Filed Aug 10 · 0d later | SEC filing |
| Chief Legal Officer | Class A Common StockSale10b5-1 | 51,700$4.51 / share | $233.17K | Jul 20Filed Jul 20 · 0d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 4,839$4.53 / share | $21.92K | Jul 17Filed Jul 17 · 0d later | SEC filing |
| Chief Executive Officer | Class A Common StockSale10b5-1 | 62,711$4.67 / share | $292.86K | Jul 15Filed Jul 16 · 1d later | SEC filing |
| CEO, Counterpart Health | Class A Common StockSale10b5-1 | 24,215$4.67 / share | $113.08K | Jul 15Filed Jul 16 · 1d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 13,119$4.67 / share | $61.27K | Jul 15Filed Jul 16 · 1d later | SEC filing |
| Chief Legal Officer | Class A Common StockSale10b5-1 | 10,519$4.67 / share | $49.12K | Jul 15Filed Jul 16 · 1d later | SEC filing |
| Interim CFO | Class A Common StockSale10b5-1 | 4,630$4.67 / share | $21.62K | Jul 15Filed Jul 16 · 1d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 2,384$4.68 / share | $11.16K | Jul 8Filed Jul 9 · 1d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 6,229$5.26 / share | $32.76K | Jul 6Filed Jul 6 · 0d later | SEC filing |
| Chief Executive Officer | Class A Common StockSale10b5-1 | 313,476$5.32 / share | $1.67M | Jul 1Filed Jul 1 · 0d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 2,360$4.78 / share | $11.28K | Jun 17Filed Jun 18 · 1d later | SEC filing |
| VP OF FINANCE AND CONTROLLER | Class A Common StockSale10b5-1 | 12,102$4.86 / share | $58.82K | Jun 16Filed Jun 17 · 1d later | SEC filing |
| Chief Legal Officer | Class A Common StockSale10b5-1 | 4,681$4.61 / share | $21.58K | Jun 15Filed Jun 16 · 1d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 6,350$4.61 / share | $29.27K | Jun 15Filed Jun 16 · 1d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 7,289$4.91 / share | $35.79K | Jun 11Filed Jun 11 · 0d later | SEC filing |
| CEO, Counterpart Health | Class A Common StockSale10b5-1 | 220,426$3.99 / share | $879.5K | May 28Filed May 28 · 0d later | SEC filing |
| Director | Class A Common StockSale | 67,160$3.42 / share | $229.69K | May 18Filed May 19 · 1d later | SEC filing |
| Interim CFO | Class A Common StockExercise-price or tax withholding | 16,942$3.47 / share | $58.79K | May 16Filed May 18 · 2d later | SEC filing |
| CEO of Clover Care Services | Class A Common StockSale | 98,039$3.52 / share | $345.1K | May 13Filed May 13 · 0d later | SEC filing |
| Chief Executive Officer | Class A Common StockExercise-price or tax withholding | 85,704$2.82 / share | $241.69K | May 8Filed May 12 · 4d later | SEC filing |
| CEO of Clover Care Services | Class A Common StockExercise-price or tax withholding | 36,113$2.19 / share | $79.09K | Apr 18Filed Apr 21 · 3d later | SEC filing |
| CEO of Clover Care Services | Class A Common StockExercise-price or tax withholding | 15,471$2.04 / share | $31.56K | Apr 15Filed Apr 16 · 1d later | SEC filing |
| Chief Legal Officer | Class A Common StockExercise-price or tax withholding | 10,161$2.04 / share | $20.73K | Apr 15Filed Apr 16 · 1d later | SEC filing |
| Chief Executive Officer | Class A Common StockExercise-price or tax withholding | 60,765$2.04 / share | $123.96K | Apr 15Filed Apr 16 · 1d later | SEC filing |
| Interim CFO | Class A Common StockExercise-price or tax withholding | 4,158$2.04 / share | $8.48K | Apr 15Filed Apr 16 · 1d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockExercise-price or tax withholding | 12,712$2.04 / share | $25.93K | Apr 15Filed Apr 16 · 1d later | SEC filing |
| CEO, Counterpart Health | Class A Common StockExercise-price or tax withholding | 23,463$2.04 / share | $47.86K | Apr 15Filed Apr 16 · 1d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockExercise-price or tax withholding | 6,197$1.72 / share | $10.66K | Apr 3Filed Apr 7 · 4d later | SEC filing |
| CEO of Clover Care Services | Class A Common StockGrant or award | 191,261Award · no purchase price | Non-cash award | Apr 1Filed Apr 3 · 2d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockGrant or award | 159,384Award · no purchase price | Non-cash award | Apr 1Filed Apr 3 · 2d later | SEC filing |
| Chief Executive Officer | Class A Common StockGrant or award | 956,307Award · no purchase price | Non-cash award | Apr 1Filed Apr 3 · 2d later | SEC filing |
| Chief Executive Officer | Class A Common StockExercise-price or tax withholding | 309,558$1.76 / share | $544.82K | Apr 1Filed Apr 3 · 2d later | SEC filing |
| CEO, Counterpart Health | Class A Common StockGrant or award | 267,766Award · no purchase price | Non-cash award | Apr 1Filed Apr 3 · 2d later | SEC filing |
| Chief Legal Officer | Class A Common StockGrant or award | 382,522Award · no purchase price | Non-cash award | Apr 1Filed Apr 3 · 2d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.